The Repurposing Drugs in Oncology (ReDO) Project
Sukhatme, Vikas P.
Vikas, P.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationPantziarka, Pan, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P. Sukhatme, and P. Vikas. 2014. “The Repurposing Drugs in Oncology (ReDO) Project.” ecancermedicalscience 8 (1): 442. doi:10.3332/ecancer.2014.442. http://dx.doi.org/10.3332/ecancer.2014.442.
AbstractThe Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12717513
- HMS Scholarly Articles